Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
SAN FRANCISCO, Aug. 30, 2016 -- Zephyr Health, the leading Insights-as-a-Service solution provider to Life Sciences companies, today launched two new, game changing analytic capabilities for Zephyr IlluminateTM. These new capabilities, Referral Analytics and Segment Analytics, previously available only for charter customers, are the latest addition to its enterprise solution that integrates thousands of disparate data sources to create precise and predictive insights.
Referral Analytics is the industry’s most innovative, machine-driven solution that identifies referral patterns to help predict and segment potential referring healthcare providers, specialists or organizations. With Referral Analytics, life sciences companies can quickly compare historical referral trends and volume, and prioritize existing or new customers based upon referral potential.
Segment Analytics provides a summary view of multiple customer groups to better analyze and target key customers and markets. Using Zephyr Illuminate’s powerful, proprietary scoring capabilities, Segment Analytics aggregates data relevant to both medical and commercial teams on key attributes such as treatment, promotional engagement, marketing influence and clinical research.
“These new capabilities prove the transformational power big data has for a life sciences business,” said William King, Founder and Executive Chairman, Zephyr Health. “With these new capabilities our customers are significantly improving their outreach strategies by easily extracting these meaningful insights - like finding the highest ranking potential referrers, or high potential treaters with low engagement - all in Zephyr Illuminate’s simple user interface.”
Zephyr Illuminate™ was cited as a vertical specialist among insights solutions providers in the May 2016 Forrester Research Report, Vendor Landscape: Insights Service Providers. Fortune 100 life sciences companies are using Zephyr Illuminate to optimize product planning, launch and sales by engaging the right physicians, accounts and institutions using insights from global health data.
About Zephyr Health
Zephyr Health helps life sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles. Zephyr Health's customers include Top 10 Pharmaceutical companies, Top 10 Biotech Companies and Top 10 Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact: Zephyr Health Global Communications [email protected]
